News|Articles|January 28, 2026
Lab to Launch Faster
Author(s)Fujifilm
Case study showcasing accelerated PPQ for an E. coli–expressed orphan therapy, achieving three PPQ batches in 18 months through high-compliance manufacturing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
2
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
3
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
4
Subvisible Particulate Matter Testing
5